Your search returned 3 results.

Results
	1.	The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy. [electronic resource] by Ghosh, Asish K Secreto, Charla Boysen, Justin Sassoon, Traci Shanafelt, Tait D Mukhopadhyay, Debabrata Kay, Neil E Producer: 20110404 In: Blood vol. 117 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells. [electronic resource] by Kay, Neil E Sassoon, Traci Secreto, Charla Sinha, Sutapa Shanafelt, Tait D Ghosh, Asish K Arbiser, Jack L Producer: 20171222 In: Leukemia & lymphoma vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis. [electronic resource] by Ding, Wei Shanafelt, Tait D Lesnick, Connie E Erlichman, Charles Leis, Jose F Secreto, Charla Sassoon, Traci R Call, Timothy G Bowen, Deborah A Conte, Michael Kumar, Shaji Kay, Neil E Producer: 20140923 In: British journal of haematology vol. 164 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)